Market closed · Next open: Monday 9:30 AM ET
Last update: Jul 17, 2026, 5:09 PM ET
Hims & Hers Health, Inc.
$32.84 2.49% today
Market Closed

Why Hims & Hers Health, Inc. (HIMS) stock moved

Updated Jul 20, 2026

Hims & Hers Health, Inc. (HIMS) shares fell 2.5% to $32.84 as of July 20, 2026, a modest decline from the prior close of $33.68. BestStocks flagged the session as a major change for HIMS. No single company-specific catalyst was confirmed during the move window. Below, we break down what changed for HIMS, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

HIMS fell 2.5% to $32.84

HIMS fell 2.5% in its latest session, moving from $33.68 to $32.84.

RiskWeak confidence
Rel. volume
0.4×
Below Avg
Vs peers
No comparable peers
Market cap
$7.3B
New York Stock Exchange
Analyst target
$30
-9.7% vs price
Price chart
Not enough price data.
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for Hims & Hers Health, Inc. investors

For Hims & Hers Health, Inc. investors, the recent signals add up to a bearish shift. On the constructive side: Hims & Hers Health, Inc. (HIMS) moved +5.75% from $35.15 to $37.17 on 2026-07-15; HIMS moved +4.02% from $36.80 to $38.28 on 2026-07-06. Weighing against that: Negative session, down 2.5%; Hims & Hers Health, Inc. (HIMS) moved -9.39% from $37.17 to $33.68 on 2026-07-16. Wall Street's consensus price target sits at $29.67, implying -9.7% downside from $32.84. BestStocks rates the overall signal quality weak (0/100). With earnings roughly 21 days out, the next report is the most likely near-term test of the move.

HIMS price reaction

HIMS last traded at $32.84, down $0.84 (-2.49%) from the previous close of $33.68. The session traded on 0.4× average volume (below avg), so participation was unremarkable.

Bullish and bearish analyst opinions on Hims & Hers Health, Inc. (HIMS)

The consensus analyst price target on Hims & Hers Health, Inc. (HIMS) is $29.67, 9.7% below the recent $32.84. Over the past 90 days analysts logged 0 upgrades, 13 maintains, and 0 downgrades. Here is how the bullish and bearish cases on HIMS line up.

The bullish case

  • The Street's most bullish target is $60.00 (+82.7%).
  • Hims & Hers Health, Inc. (HIMS) moved +5.75% from $35.15 to $37.17 on 2026-07-15.
  • HIMS moved +4.02% from $36.80 to $38.28 on 2026-07-06.
  • Positive price momentum.

The bearish case

  • The consensus analyst price target of $29.67 sits 9.7% below the recent $32.84, so the average target sees limited room to run.
  • The most bearish analyst target is $12.50 (-61.9%).
  • Negative session, down 2.5%.
  • Hims & Hers Health, Inc. (HIMS) moved -9.39% from $37.17 to $33.68 on 2026-07-16.
Bull vs bear balanceBearish Shift
BearishNeutralBullish

Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Jul 19, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $30-9.7%
= 13 maintains
B of A Securities maintained Neutral · 2026-07-09
SEC filings watch
8-K2026-07-17
Material event — review for impact
high
8-K2026-07-01
Material event — review for impact
high
8-K2026-06-15
Material event — review for impact
high
8-K2026-06-02
Material event — review for impact
high
Peer context
HIMS-2.5%

Previous notable changes for HIMS

Filings2026-07-17
Hims & Hers Health, Inc. (HIMS) filed an 8-K on July 17, 2026. The audit contains only the filing notification itself; the specific content and purpose of the 8-K were not detailed in available evidence.
Activity2026-07-15
Hims & Hers Health, Inc. (HIMS) moved +5.75% from $35.15 to $37.17 on 2026-07-15.
Risk2026-07-10
Hims & Hers Health, Inc. (HIMS) moved −3.02% from $35.45 to $34.38 on July 10, 2026. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume traded near its 5-day average, indicating no unusual trading activity.
Risk2026-07-08via Seeking Alpha
Hims & Hers Health, Inc. moved -9.04% intraday from $38.28 to $34.82. Hims & Hers Health: The Market Still Doesn't Get It: FDA staff challenged seven compounded peptides, but Hims & Hers continues expanding internationally and strengthening its core healthcare platform beyond longevity therapies. The $400 million JPMorgan receivables facilit [2026-07-08]
Upcoming catalysts & outlook
Next earnings
2026-08-10 (est.)
in 21 days
Thesis shift
Bearish Shift
bearish signal
Risk level
High
from change events

Frequently asked questions about HIMS

Why did Hims & Hers Health, Inc. (HIMS) stock move?

HIMS fell 2.5% to $32.84. No single company-specific catalyst was confirmed during the move window, and it looks technical.

How much did HIMS stock fall?

HIMS lost 2.49% ($0.84) versus the prior close of $33.68, last trading at $32.84 on 0.4× average volume.

When is Hims & Hers Health, Inc.'s next earnings date?

HIMS's next earnings report is estimated for 2026-08-10 — about 21 days away.

What is the analyst price target for HIMS?

The consensus analyst price target for HIMS is $29.67, about 9.7% below the current $32.84. Over the past 90 days, analysts recorded 0 upgrades, 13 maintains, and 0 downgrades.

How BestStocks tracks HIMS

This page is generated automatically by BestStocks' change-detection system after its price and volume cleared HIMS-specific materiality thresholds, triggering an evidence check. It draws on 11 tracked change events for HIMS, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of July 20, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataSEC EDGAR filingsFMP earnings & estimatesAnalyst ratings & price targets (FMP)Earnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.